A mitochondrial electron transport chain with atypical subunit composition confers oxygen sensitivity to a mammalian chemoreceptor

Abstract

The carotid body (CB) is the major chemoreceptor for blood oxygen in the control of ventilation in mammals, contributing to physiological adaptation to high altitude, pregnancy, and exercise, and its hyperactivity is linked to chronic conditions such as sleep-disorder breathing, hypertension, chronic heart failure, airway constriction, and metabolic syndrome. Upon acute hypoxia (PO2=100 mmHg to <80 mmHg), K+ channels on CB glomus cells are inhibited, causing membrane depolarization to trigger Ca+2 influx and neurotransmitter release that stimulates afferent nerves. A longstanding model proposes that the CB senses hypoxia through atypical mitochondrial electron transport chain (ETC) metabolism that is more sensitive to decreases in oxygen than other tissues. This model is supported by observations that ETC inhibition by pharmacology and gene knockout activates CB sensory activity and that smaller decreases in oxygen concentration inhibit ETC activity in CB cells compared to other cells. Determining the composition of atypical ETC subunits in the CB and their specific activities is essential to delineate molecular mechanisms underlying the mitochondrial hypothesis of oxygen sensing. Here, we identify HIGD1C, a novel hypoxia inducible gene domain factor isoform, as an ETC Complex IV (CIV) protein highly and selectively expressed in glomus cells that mediates acute oxygen sensing by the CB. We demonstrate that HIGD1C negatively regulates oxygen consumption by CIV and acts with the hypoxia-induced CIV subunit COX4I2 to enhance the sensitivity of CIV to hypoxia, constituting an important component of mitochondrial oxygen sensing in the CB. Determining how HIGD1C and other atypical CIV proteins expressed in the CB work together to confer exquisite oxygen sensing to the ETC will help us better understand how tissue- and condition-specific CIV subunits contribute to physiological function and disease and allow us to potentially target these proteins to treat chronic diseases characterized by CB dysfunction.

Developmental heterogeneity of embryonic neuroendocrine chromaffin cells and their maturation dynamics

“…Some of the terminal population-specific markers, for instance Higd1c, Rgs5 and Scg2 are involved in the downstream response following hypoxia-sensing (Jin, An et al 2009, Fang, Dai et al 2021, Timón-Gómez 2021). We experimentally validated their expression in adrenal medulla and found population-specific expression in the previously identified oxygen-sensing cells (cluster ChC2).…”

Developmental heterogeneity of embryonic neuroendocrine chromaffin cells and their maturation dynamics

“…Some of the terminal population-specific markers, for instance Higd1c, Rgs5 and Scg2 are involved in the downstream response following hypoxia-sensing ( 46 – 49 ). We experimentally validated their expression in adrenal medulla and found population-specific expression in the previously identified high oxygen-sensing cells (cluster ChC2).…”